Conivaptan
Modify Date: 2025-08-25 09:22:18
Conivaptan structure
|
Common Name | Conivaptan | ||
|---|---|---|---|---|
| CAS Number | 210101-16-9 | Molecular Weight | 498.574 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 751.2±60.0 °C at 760 mmHg | |
| Molecular Formula | C32H26N4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 408.1±32.9 °C | |
Use of ConivaptanA potent, selective, nonpeptide vasopressin V1A and V2 receptor antagonist with Ki of 0.48 nM and 3.04 nM respectively. |
| Name | conivaptan |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 751.2±60.0 °C at 760 mmHg |
| Molecular Formula | C32H26N4O2 |
| Molecular Weight | 498.574 |
| Flash Point | 408.1±32.9 °C |
| Exact Mass | 498.205566 |
| PSA | 78.09000 |
| LogP | 4.40 |
| Vapour Pressure | 0.0±2.5 mmHg at 25°C |
| Index of Refraction | 1.699 |
| [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(3H)-yl)carbonyl]phenyl]- |
| [1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]- |
| YM087 |
| Conivaptan (INN) |
| N-{4-[(2-Methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(3H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide |
| UNII-0NJ98Y462X |
| Conivaptan |
| N-{4-[(2-Methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}-2-biphenylcarboxamide |
| N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide |